Holen Sie sich die Stockscreener-App
0.4674
8.44%
-0.0431
Handel nachbörslich:
.49
0.0226
+4.84%
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Scienture Holdings (SCNX) Co-CEO granted 500,000 restricted shares - Stock Titan
Scienture secures GPO deals for naloxone nasal spray - Investing.com India
Scienture secures GPO deals for naloxone nasal spray By Investing.com - Investing.com Nigeria
SCNX Expands Market Reach with New GPO Agreements - GuruFocus
SCIENTURE Broadens Commercial Access for REZENOPY, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions - Bitget
SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions - The Manila Times
High-dose overdose spray REZENOPY set to reach 5,000 US care sites - Stock Titan
EXCLUSIVE: Scienture Expands Reach For Opioid Overdose Treatment, With Deals Covering 60% Of US Institutional Market - Benzinga
What makes Scienture Holdings Inc. stock attractive to growth funds2025 AllTime Highs & High Conviction Buy Zone Alerts - Naître et grandir
Why Scienture Holdings Inc. stock remains a top recommendationMarket Activity Recap & Daily Profit Focused Stock Screening - Naître et grandir
Is Scienture Holdings Inc. stock a top pick in earnings seasonWeekly Trade Review & Proven Capital Preservation Tips - Naître et grandir
Why Is Scienture Stock Rising Today? - Stocktwits
SCNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SCNX Earnings History & Surprises | EPS & Revenue Results | SCIENTURE HOLDINGS INC (NASDAQ:SCNX) - ChartMill
Aug Spikes: What is Scienture Holdings Incs market position2025 Big Picture & Community Supported Trade Ideas - baoquankhu1.vn
SCNX Should I Buy - Intellectia AI
Scienture Holdings, Inc.: Target Price Consensus and Analysts Recommendations | | US80880X1046 - marketscreener.com
Scienture Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | | US80880X1046 - marketscreener.com
SCNX Technical Analysis & Stock Price Forecast - Intellectia AI
Scienture Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | SCNX | US80880X1046 - marketscreener.com
Scienture (NASDAQ:SCNX) Coverage Initiated by Analysts at Maxim Group - Defense World
Maxim Group Initiates Coverage on Scienture Holdings (SCNX) with a 'Buy' Rating | SCNX Stock News - GuruFocus
Maxim Group Initiates Coverage of Scienture Holdings (SCNX) with Buy Recommendation - Nasdaq
What are analysts’ price targets for Scienture Holdings Inc.2025 Year in Review & Fast Gaining Stock Reports - mfd.ru
Aug Movers: What is Scienture Holdings Incs market positionWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Gainers Report: What is Scienture Holdings Incs market positionBond Market & Weekly Breakout Stock Alerts - baoquankhu1.vn
Why Scienture Holdings Inc. (4E4) stock is upgraded to buyProfit Target & Long-Term Safe Investment Plans - mfd.ru
Is Scienture Holdings Inc. stock a good pick for beginnersJuly 2025 Highlights & Low Risk Profit Maximizing Plans - mfd.ru
Aug Levels: Is Scienture Holdings Inc stock heavily shortedWeekly Profit Analysis & Smart Swing Trading Alerts - baoquankhu1.vn
Scienture reports progress on ARBLI, confirms REZENOPY launch By Investing.com - Investing.com Nigeria
SCNX: Scienture Updates on Arbli and Future Product Launch - GuruFocus
Scienture reports progress on ARBLI, confirms REZENOPY launch - Investing.com
SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times
Scienture Provides Commercial Update on ARBLI , the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium - marketscreener.com
Signal Recap: Does InvenTrust Properties Corp stock have upside surprise potentialAnalyst Downgrade & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Is Scienture Holdings Inc gaining market share2025 Technical Overview & AI Enhanced Trading Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Scienture appoints Hariharan, Mani as co-CEOs - MSN
Growth Value: Will Scienture Holdings Inc benefit from geopolitical trendsWeekly Trading Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
EPS Watch: What is Scienture Holdings Incs book value per share2025 Technical Overview & Expert Approved Momentum Ideas - baoquankhu1.vn
Risk On: Is Scienture Holdings Inc stock heavily shortedMarket Risk Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Will Scienture Holdings Inc. stock recover faster than peersQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com
Aug Spikes: Is EHTH stock forming a cup and handleOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn
EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment - Sahm
Head to Head Review: Scienture (NASDAQ:SCNX) & Aldeyra Therapeutics (NASDAQ:ALDX) - Defense World
Scienture receives patent for high-dose naloxone nasal spray By Investing.com - Investing.com Nigeria
Scienture And Summit's REZENOPY Awarded Orange Book-Listable Patent, Valid Till 2041 - Nasdaq
SCNX Secures Patent for REZENOPY Nasal Spray Until 2041 - GuruFocus
Scienture receives patent for high-dose naloxone nasal spray - Investing.com
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment - The Manila Times
New patent backs 10 mg naloxone spray for life-saving overdose treatment - Stock Titan
AI Stocks: Will Scienture Holdings Inc stock outperform international peersPortfolio Gains Report & Community Verified Swing Trade Signals - Bộ Nội Vụ
Aug PreEarnings: Will Escalade Incorporated stock hit new highs in YEAR - baoquankhu1.vn
MSN Money - MSN
Scienture Holdings Inc (SCNX) - MSN
Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Scienture Holdings, Inc.Common Stock (NQ: SCNX - FinancialContent
1.80%
10.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):